Detalhe da pesquisa
1.
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.
Cell
; 185(14): 2591-2608.e30, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803246
2.
A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity.
J Pharmacol Exp Ther
; 361(1): 39-50, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28154014
3.
Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation.
Nat Cancer
; 5(3): 433-447, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38286827
4.
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens.
Nat Genet
; 55(1): 19-25, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624340
5.
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
Nat Commun
; 14(1): 8435, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114518
6.
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity.
Cancer Cell
; 41(7): 1207-1221.e12, 2023 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327789
7.
Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation.
Front Cell Dev Biol
; 8: 627090, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33681186
8.
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
Nat Commun
; 15(1): 225, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172131